Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Operating Activities
Net income	$ 14,514	$ 16,203	$ 11,558
Adjustments to reconcile net income to net cash flows provided by operating activities:
Change in deferred policy acquisition costs	3,223	(5,754)	(2,096)
Depreciation and amortization	8,029	4,628	3,507
Deferred income tax expense	3,397	4,881	3,411
Net realized (gains) losses	(4,193)	(650)	(54)
Loss on sale of subsidiary	477	0	0
Stock-based compensation expense	763	176	209
Amortization of premiums and discounts on investments	609	348	197
Non-controlling interest	(170)	(772)	(184)
Change in allowance for doubtful accounts	(112)	(30)	(100)
Changes in operating assets and liabilities, net of the effects of acquisitions
Accrued investment income	(16)	30	285
Other receivables	(1,281)	4,874	1,148
Reinsurance recoverables	(5,181)	4,416	25,225
Other assets	(311)	(1,600)	(109)
Unpaid claims	(315)	(3,459)	(211)
Unearned premiums	14,330	(5,222)	(27,894)
Accrued expenses, accounts payable and other liabilities	(13,618)	(8,148)	(1,499)
Deferred revenue	(7,309)	3,181	0
Net cash flows (used in) provided by operating activities	12,836	13,102	13,393
Investing activities
Proceeds from maturities, calls and prepayments of available-for-sale investments	9,701	12,114	12,323
Proceeds from sales of available-for-sale investments	62,300	8,769	14,376
Proceeds from maturities of short term investments	300	50	960
Purchases of available-for-sale investments	(63,757)	(24,047)	(8,326)
Purchases of property and equipment	(6,280)	(9,191)	(1,974)
Net (paid) for acquisitions of subsidiaries, net of cash received	(50,143)	(20,548)	(38,577)
Sale of subsidiary, net of cash paid	(153)	0	0
Proceeds from notes receivable	(975)	684	120
Change in restricted cash	1,542	2,368	(5,434)
Net cash flows used in investing activities	(47,465)	(29,801)	(26,532)
Financing activities
Payments on notes payable	(74,263)	(20,000)	(13,600)
Proceeds from notes payable	110,550	25,226	25,087
Capitalized closing costs for notes payable	0	(1,379)	0
Payments for intial public offering costs	(826)	40,703	5,611
Payments on redeemable preferred stock	(11,040)	(500)
Stockholder funds disbursed at purchase	0	(14,105)	0
Net proceeds from exercise of stock options	607	117	24
Excess tax benefits from stock-based compensation	45	86	0
(Purchase) issuance of treasury stock	(2,552)	0	3,875
Stock Issued During Period, Value, Employee Stock Purchase Plan	58	0	0
Net cash flows provided by financing activities	22,579	30,148	20,997
Net (decrease) increase in cash and cash equivalents	(12,050)	13,449	7,858
Cash and cash equivalents, beginning of period	43,389	29,940	22,082
Cash and cash equivalents, end of period	31,339	43,389	29,940
Supplemental disclosures of cash payments for:
Interest	6,184	7,246	7,728
Income taxes	3,451	5,316	3,806
Non-cash consideration received from the sale of subsidiary	$ 1,143	$ 0	$ 0